The Odds Ratio Product (An Objective Sleep Depth Measure): Normal Values, Repeatability, and Change With CPAP in Patients With OSA.


Journal

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
ISSN: 1550-9397
Titre abrégé: J Clin Sleep Med
Pays: United States
ID NLM: 101231977

Informations de publication

Date de publication:
15 08 2019
Historique:
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 21 10 2020
Statut: ppublish

Résumé

The Odds Ratio Product (ORP) is an objective measure of sleep depth using the relationships of the powers of different electroencephalogram (EEG) frequencies in a single index. The range of the ORP is 0 (deeply asleep) to 2.5 (fully awake). This investigation seeks to elucidate normal values of non-rapid eye movement ORP (ORP Healthy individuals underwent a home sleep apnea test (HSAT) with EEG followed 1 week later by EEG alone. Another cohort with OSA underwent baseline HSAT with EEG followed by a second EEG study approximately 4 weeks into treatment with CPAP. Thirty-eight healthy individuals completed the protocol (mean age of 34.9 ± 7.4 years, Epworth Sleepiness Scale score 3.6 ± 2.4, Insomnia Severity Index score 2.0 ± 1.6 and Functional Outcomes of Sleep Questionnaire - shorter version score 19 ± 1.2). The mean ORP The ORP Penner CG, Gerardy B, Ryan R, Williams M. The odds ratio product (an objective sleep depth measure): normal values, repeatability, and change with CPAP in patients with OSA. J Clin Sleep Med. 2019;15(8):1155-1163.

Identifiants

pubmed: 31482838
doi: 10.5664/jcsm.7812
pmc: PMC6707046
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1155-1163

Informations de copyright

© 2019 American Academy of Sleep Medicine.

Références

Sleep Med. 2001 May;2(3):215-223
pubmed: 11311684
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1459-63
pubmed: 11704596
Clin Neurophysiol. 2005 Sep;116(9):2228-39
pubmed: 16040272
Nihon Kokyuki Gakkai Zasshi. 2005 Oct;43(10):578-82
pubmed: 16285588
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:123-34
pubmed: 19218636
Sleep. 2009 Jul;32(7):915-9
pubmed: 19639754
Respirology. 2012 Apr;17(3):547-53
pubmed: 22309157
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
Electroencephalogr Clin Neurophysiol. 1986 Jan;63(1):10-7
pubmed: 2416530
Sleep. 2015 Apr 01;38(4):641-54
pubmed: 25348125
J Clin Sleep Med. 2015 Aug 15;11(8):931-52
pubmed: 26235159
J Appl Physiol (1985). 2016 Apr 1;120(7):801-8
pubmed: 26718786
J Clin Sleep Med. 2017 Feb 15;13(2):245-258
pubmed: 27784419
Front Neurol. 2017 Jun 28;8:289
pubmed: 28701992
Sleep Med. 2017 Dec;40:84-93
pubmed: 29221784
J Sleep Res. 1997 Jun;6(2):128-33
pubmed: 9377532

Auteurs

Charles Gerhard Penner (CG)

University of Manitoba, Winnipeg, Canada; Cerebra Health Inc., Winnipeg, Canada; RANA Respiratory Care Group, Brandon, Manitoba.

Bethany Gerardy (B)

Cerebra Health Inc., Winnipeg, Canada.

Rob Ryan (R)

RANA Respiratory Care Group, Brandon, Manitoba.

Mark Williams (M)

Cerebra Health Inc., Winnipeg, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH